Generics - Eli Lilly, North America

Filter

Current filters:

Eli LillyNorth America

Popular Filters

Teva gains approval for generic Evista in the USA

Teva gains approval for generic Evista in the USA

04-03-2014

Israel-based Teva Pharmaceutical Industries says it has received approval from the US Food and Drug Administration…

Anti-Arthritics/RheumaticsEli LillyEvistaGenericsNorth AmericaRegulationTeva Pharmaceutical IndustriesUSA

Actavis confirms challenge of Lilly’s Axiron patent

Actavis confirms challenge of Lilly’s Axiron patent

14-11-2013

US generics major Actavis confirms that it has filed an Abbreviated New Drug Application with the US…

ActavisAxironEli LillyGenericsLegalMen's HealthNorth AmericaPatentsRegulation

Shire settles with Actavis/Watson over Intuniv; Lilly sues J&J

26-04-2013

Ireland-headquartered Shire (LSE: SHP) says it has settled all pending litigation with Actavis (NYSE:…

ActavisEli LillyGenericsIntunivJohnson & JohnsonNeurologicalNorth AmericaPatentsPharmaceuticalShiresolanezumabWatson Pharmaceuticals

Prasco selected as Eli Lilly authorized generics partner for Zyprexa

20-10-2011

Privately-held US drugmaker Prasco Laboratories says it has signed a marketing and distribution agreement…

Eli LillyGenericsMarkets & MarketingNeurologicalNorth AmericaPrasco LaboratoriesZyprexa

Company Spotlight

ImmunoGen

ImmunoGen

Back to top